Back to Journals » Neuropsychiatric Disease and Treatment » Volume 15

Changes In Plasma NPY, IL-1β And Hypocretin In People Who Died By Suicide

Authors Lu J, Li S, Li H, Mou T, Zhou L, Huang B, Huang M, Xu Y

Received 19 June 2019

Accepted for publication 12 September 2019

Published 10 October 2019 Volume 2019:15 Pages 2893—2900

DOI https://doi.org/10.2147/NDT.S219962

Checked for plagiarism Yes

Review by Single-blind

Peer reviewers approved by Prof. Dr. Roumen Kirov

Peer reviewer comments 3

Editor who approved publication: Dr Yu-Ping Ning


Jing Lu,1 Shangda Li,1 Haimei Li,1 Tingting Mou,1 Lihong Zhou,2 Bochao Huang,1 Manli Huang,1 Yi Xu1

1The Key Laboratory of Mental Disorder Management in Zhejiang Province, Department of Psychiatry, First Affiliated Hospital, College of Medicine, Zhejiang University, Zhejiang University Brain Research Institute, Hangzhou, Zhejiang Province, People’s Republic of China; 2Institute of Criminal Science and Technology, Hangzhou Public Security Bureau, Hangzhou, Zhejiang Province, People’s Republic of China

Correspondence: Yi Xu; Manli Huang
The Key Laboratory of Mental Disorder Management in Zhejiang Province, Department of Psychiatry, The First Affiliated Hospital, Zhejiang University School of Medicine, 79 Qing Chun Road, Hangzhou 310003, People’s Republic of China
Tel/fax +86-571-8723-5995
Email xuyizju@zju.edu.cn; huangmanli@zju.edu.cn

Purpose: There is growing evidence showing that inflammatory cytokines and neuropeptides may be involved in the pathophysiology of suicidal behavior. However, studies have yielded contradictory data, and no biological markers that help predict suicide have been identified. This study aimed to identify biological patterns, such as NPY, IL-1β and hypocretin plasma levels, in people who died by suicide.
Patients and methods: Twenty-two people who died by suicide compared with 22 controls matched for age and sex were studied. In suicide and control subjects, we estimated the levels of NPY, IL-1β and hypocretin in plasma using enzyme-linked immunosorbent assay. The data are presented as the median (25th–75th percentile).
Results: We found (1) a significant elevation in plasma NPY levels in suicide subjects versus control subjects (suicide: 11.38 (9.380–16.55); controls: 8.95 (7.590–10.93); P=0.013), and plasma NPY concentrations were approximately 62% higher in suicide subjects than those in control subjects; (2) a significant decrease in plasma IL-1β concentrations between suicide and control subjects (suicide: 121.1 (82.97–143.0); controls: 425.9 (233.1–835.3); P<0.001) as well as a decrease in IL-1β concentrations by almost 80%; and (3) no significant difference in plasma hypocretin levels between suicide and control subjects (suicide: 16.62 (13.62–25.77); controls: 21.63 (14.97–29.72); P=0.356).
Conclusion: Our results suggest that plasma NPY and IL-1β were related with suicide behavior rather than to suicide causes or suicide method. Specific combinations of plasma biomarkers may discriminate between types of suicidal behaviors and indicate increased risk for future suicide attempts.

Keywords: plasma biomarkers, suicide behavior, suicide causes, suicide method

Creative Commons License This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.

Download Article [PDF]  View Full Text [HTML][Machine readable]